Corcept Therapeutics (CORT) Balance Sheet

Click line-items for a historical chart and %

Assets
Cash and cash equivalents	47.87M
Prepaid expenses and other current assets	1.35M
Total current assets	59.78M
Property and equipment , net of accumulated depreciation	145K
Other assets	24K
Total assets	62.93M
Liabilities and stockholders' equity
Accounts payable	4.31M
Accrued clinical expenses	6.87M
Accrued compensation
Other accrued liabilities
Total current liabilities	31.68M
Commitments	0
Stockholders' equity:
Preferred stock
Common stock	111K
Additional paid-in capital	358M
Notes receivable from stockholders
Deficit accumulated during the development stage	-326.87M
Total stockholders' equity	31.25M
Total liabilities and stockholders' equity	62.93M

Entities mentioned with CORT